Comparative Effectiveness of Nintedanib and Pirfenidone in Patients Diagnosed With Idiopathic Pulmonary Fibrosis

被引：0
作者：
Shankar, D. [1 ]
Law, A. [1 ]
Walkey, A. J. [1 ]
Hawkins, F. J. [1 ]
Alysandratos, K. [2 ]
Wilson, K. C. [1 ]
Bosch, N. A. [1 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Pulm, Boston, MA 02118 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2481
引用
收藏
页数：2
相关论文
共 50 条
[31]   Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis [J].
Cameli, Paolo ;
Bergantini, Laura ;
D'Alessandro, Miriana ;
Refini, Rosa Metella ;
Pieroni, Maria ;
Alonzi, Valerio ;
Sestini, Piersante ;
Bargagli, Elena .
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[32]   Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study [J].
Marijic, Pavo ;
Schwarzkopf, Larissa ;
Schwettmann, Lars ;
Ruhnke, Thomas ;
Trudzinski, Franziska ;
Kreuter, Michael .
RESPIRATORY RESEARCH, 2021, 22 (01)
[33]   SINGLE CENTRE EXPERIENCE OF SWITCHING PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS FROM PIRFENIDONE TO NINTEDANIB [J].
Rathnapala, A. ;
Fries, A. ;
Ruggiero, C. ;
Ho, L. P. ;
Hoyles, R. K. .
THORAX, 2016, 71 :A60-A60
[34]   HEPATIC DISORDERS OF PIRFENIDONE OR NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) A SYSTEMATIC REVIEW [J].
Singla, D. ;
Mahapatra, S. ;
Dey, A. ;
John, A. .
VALUE IN HEALTH, 2022, 25 (12) :S218-S218
[35]   Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study [J].
Pavo Marijic ;
Larissa Schwarzkopf ;
Lars Schwettmann ;
Thomas Ruhnke ;
Franziska Trudzinski ;
Michael Kreuter .
Respiratory Research, 22
[36]   Safety, Tolerability and Efficacy of Nintedanib Switched from Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis [J].
Ikeda, S. ;
Sekine, A. ;
Baba, T. ;
Katano, T. ;
Matama, G. ;
Aiko, N. ;
Isomoto, K. ;
Otoshi, R. ;
Tabata, E. ;
Shintani, R. ;
Sadoyama, S. ;
Yamakawa, H. ;
Niwa, T. ;
Nakagawa, H. ;
Oda, T. ;
Okuda, R. ;
Kitamura, H. ;
Komatsu, S. ;
Hagiwara, E. ;
Ogura, T. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[37]   Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe [J].
Kaushal, Mohit ;
Talwar, Dhruv ;
Prajapat, Deepak ;
Kumar, Sunil ;
Acharya, Sourya ;
Talwar, Deepak .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
[38]   Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis [J].
Siri T. Lehtonen ;
Anniina Veijola ;
Henna Karvonen ;
Elisa Lappi-Blanco ;
Raija Sormunen ;
Saara Korpela ;
Ulrika Zagai ;
Magnus C. Sköld ;
Riitta Kaarteenaho .
Respiratory Research, 17
[39]   Pirfenidone and Nintedanib Therapy for Idiopathic Pulmonary Fibrosis: A Tertiary Centre Experience [J].
Diab, N. ;
Mao, T. ;
Danoff, S. K. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[40]   Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis [J].
Lehtonen, Siri T. ;
Veijola, Anniina ;
Karvonen, Henna ;
Lappi-Blanco, Elisa ;
Sormunen, Raija ;
Korpela, Saara ;
Zagai, Ulrika ;
Skold, Magnus C. ;
Kaarteenaho, Riitta .
RESPIRATORY RESEARCH, 2016, 17
12345